8-K: Femasys Executes 1-for-20 Reverse Stock Split
Corporate Action Announcement
Femasys Inc. has implemented a 1-for-20 reverse stock split of its common stock, effective June 5, 2026.
Summary
- Femasys Inc. completed a 1-for-20 reverse stock split of its outstanding common stock.
- The amendment was filed with the Delaware Secretary of State and became effective at 8:40 a.m. ET on June 5, 2026.
- Every 20 shares of common stock were automatically combined into one share.
- The action was previously authorized by stockholders at a special meeting on April 29, 2026.
- Proportionate adjustments were made to outstanding stock options, RSUs, and warrants, including an increase in exercise prices.
- No fractional shares will be issued; fractional shares will be rounded up to the nearest whole share at the DTC participant level.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral-to-negative event; while it is a necessary administrative step for exchange compliance, it often signals that the stock price has fallen significantly.
Positives
- The reverse stock split is a standard corporate action often used to maintain compliance with Nasdaq listing requirements regarding minimum bid prices.
Negatives
- Reverse stock splits are frequently perceived by the market as a sign of financial distress or a failure to maintain organic share price growth.
Risks
- Potential negative market sentiment following the announcement of a reverse stock split.
- Risk of continued downward pressure on share price if underlying business fundamentals do not improve.
Future Outlook
The company will continue trading on the Nasdaq Capital Market on a split-adjusted basis starting June 8, 2026.
Industry Context
StockSavvy.ai notes that reverse stock splits are common among small-cap and micro-cap biotech companies attempting to regain compliance with exchange minimum bid price rules to avoid delisting.
Comparison to Industry Standards
- The 1-for-20 ratio is consistent with standard practices for companies seeking to significantly boost their per-share price to meet Nasdaq listing thresholds.
- Rounding up fractional shares is a standard procedure to minimize administrative complexity for shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Effected a 1-for-20 reverse stock split. | 2026-06-05 | Reduces total outstanding shares and increases per-share price proportionately. |
Stakeholder Impact
- Shareholders will see a reduction in the number of shares held, offset by a proportional increase in the price per share.
- Equity compensation plan participants will see a reduction in the number of shares reserved for issuance.
Next Steps
- Commencement of trading on a split-adjusted basis on June 8, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-04-29 | Special meeting of stockholders where the reverse stock split was authorized. |
| 2026-06-05 | Effective date and time of the reverse stock split (8:40 a.m. ET). |
| 2026-06-08 | Common stock begins trading on a split-adjusted basis on the Nasdaq Capital Market. |
Recommendation
holdA reverse stock split is a technical adjustment and does not change the underlying value of the company. Investors should hold until further operational or financial results provide clarity on the company's growth trajectory.
Keywords
Femasys, FEMY, reverse stock split, Nasdaq, corporate governance, equity adjustment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.